Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome

American Journal of Gastroenterology

Volumn 96, Issue 2, 2001, Pages 455-459

  Watson, Maria E ^a   Lacey, Loretto ^b   Kong, Steven ^a   Northcutt, Allison R ^a   McSorley, David ^a   Hahn, Beth ^a   Mangel, Allen W ^a  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EMOTION; FEMALE; HUMAN; IRRITABLE COLON; MAJOR CLINICAL STUDY; MENTAL HEALTH; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL AROUSAL; SLEEP; SOCIAL INTERACTION;

CARBOLINES; COLONIC DISEASES, FUNCTIONAL; DIARRHEA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEROTONIN ANTAGONISTS; TIME FACTORS;

EID: 0035123901     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02318-2     Document Type: Article

References (26)

1. US householder survey of functional GI disorders
2. Irritable bowel syndrome: A technical review for practice guideline development
3. Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome
4. Patient-perceived severity of irritable bowel syndrome in relation to symptoms, health resource utilization and quality of life
5. Clinical economics review: Irritable bowel syndrome
6. Impact of irritable bowel syndrome on quality of life
7. Physical symptom severity, psychological and social dysfunction in a series of outpatients with IBS
8. Toward a better understanding of patients with irritable bowel syndrome
9. Psychological aspects of nonulcer dyspepsia. A psychosomatic view focusing on a comparison between the irritable bowel syndrome and peptic ulcer disease
10. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom
11. 3 receptor antagonist, in the treatment of nonconstipated female IBS patients
12. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomized, placebo-controlled trial
13. Irritable bowel syndrome: Prevalence, prognosis, and consequences
14. Functional bowel disorders and functional abdominal pain
15. 3receptor antagonist, delays colonic transit in both patients with irritable bowel syndrome and healthy volunteers
16. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome
17. Minimum meaningful difference scores for the irritable bowel syndrome quality of life questionnaire (IBS-QOL)
18. Determining a minimal important change in a disease-specific quality of life questionnaire
19. Measurement of health status: Ascertaining the minimally clinically important difference
20. Quality of life in irritable bowel syndrome (IBS): Does it improve with resolution of symptoms?
21. Symptomology, quality of life and economic features of irritable bowel syndrome - The effect of hypnotherapy
22. Fedotozine in irritable bowel syndrome: Results of a 6-wk placebo controlled multi-center therapeutic trial
23. Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease
24. Quality of life in persons with irritable bowel syndrome. Development and validation of a new medicine
25. Quality of life in irritable bowel syndrome, effect of therapy
26. Development of a questionnaire to measure quality of life in patients with irritable bowel syndrome